Compare RGEN & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | NOV |
|---|---|---|
| Founded | 1981 | 1862 |
| Country | United States | United States |
| Employees | 2000 | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 7.4B |
| IPO Year | 1995 | 1996 |
| Metric | RGEN | NOV |
|---|---|---|
| Price | $186.76 | $20.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 15 |
| Target Price | ★ $167.67 | $19.47 |
| AVG Volume (30 Days) | 853.9K | ★ 2.8M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.24 | 0.05 |
| Revenue | $141,236,000.00 | ★ $8,744,000,000.00 |
| Revenue This Year | $14.30 | N/A |
| Revenue Next Year | $14.52 | $3.81 |
| P/E Ratio | $752.96 | ★ $403.00 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $12.31 |
| 52 Week High | $188.73 | $21.93 |
| Indicator | RGEN | NOV |
|---|---|---|
| Relative Strength Index (RSI) | 62.97 | 39.82 |
| Support Level | $158.15 | $19.77 |
| Resistance Level | $188.73 | $20.01 |
| Average True Range (ATR) | 5.68 | 0.57 |
| MACD | 0.33 | -0.19 |
| Stochastic Oscillator | 94.17 | 7.05 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
NOV (formerly National Oilwell Varco) designs, manufactures, and sells a wide range of equipment and components supplying the oil and gas industry, including rig equipment, downhole tools, drill pipe, and well casing. NOV's customers include major integrated oil companies, national oil companies, independent oil and gas companies, and drilling contractors. Its operations are organized into two reportable segments: energy products and services and energy equipment. NOV operates on a global scale, with international markets contributing nearly two-thirds of its annual revenue.